Auffret M - Search Results

1

Access to device-aided therapies in advanced Parkinson's disease: navigating clinician biases, patient preference, and prognostic uncertainty.

Auffret M, Weiss D, Stocchi F, Vérin M, Jost WH. Auffret M, et al. J Neural Transm (Vienna). 2023 Nov;130(11):1411-1432. doi: 10.1007/s00702-023-02668-9. Epub 2023 Jul 12. J Neural Transm (Vienna). 2023. PMID: 37436446 Free PMC article. Review.

2

Evaluating Cognitive Action Control Using Eye-Movement Analysis: An Oculomotor Adaptation of the Simon Task.

Duprez J, Houvenaghel JF, Naudet F, Dondaine T, Auffret M, Robert G, Drapier D, Argaud S, Vérin M, Sauleau P. Duprez J, et al. Among authors: auffret m. Front Hum Neurosci. 2016 Mar 2;10:84. doi: 10.3389/fnhum.2016.00084. eCollection 2016. Front Hum Neurosci. 2016. PMID: 26973499 Free PMC article.

3

Does Facial Amimia Impact the Recognition of Facial Emotions? An EMG Study in Parkinson's Disease.

Argaud S, Delplanque S, Houvenaghel JF, Auffret M, Duprez J, Vérin M, Grandjean D, Sauleau P. Argaud S, et al. Among authors: auffret m. PLoS One. 2016 Jul 28;11(7):e0160329. doi: 10.1371/journal.pone.0160329. eCollection 2016. PLoS One. 2016. PMID: 27467393 Free PMC article.

4

Enhanced Impulsive Action Selection in Middle-Aged Adults-Insights From an Oculomotor Simon Task.

Duprez J, Houvenaghel JF, Argaud S, Naudet F, Dondaine T, Auffret M, Robert G, Drapier D, Vérin M, Sauleau P. Duprez J, et al. Among authors: auffret m. Front Aging Neurosci. 2016 Oct 25;8:251. doi: 10.3389/fnagi.2016.00251. eCollection 2016. Front Aging Neurosci. 2016. PMID: 27826239 Free PMC article.

5

Apomorphine pump in advanced Parkinson's disease: Effects on motor and nonmotor symptoms with brain metabolism correlations.

Auffret M, Le Jeune F, Maurus A, Drapier S, Houvenaghel JF, Robert GH, Sauleau P, Vérin M. Auffret M, et al. J Neurol Sci. 2017 Jan 15;372:279-287. doi: 10.1016/j.jns.2016.11.080. Epub 2016 Dec 2. J Neurol Sci. 2017. PMID: 28017228

6

Continuous subcutaneous apomorphine infusion does not impair the dynamics of cognitive action control in mild to moderate Parkinson's disease.

Duprez J, Houvenaghel JF, Drapier S, Auffret M, Drapier D, Robert G, Vérin M, Sauleau P. Duprez J, et al. Among authors: auffret m. J Neurol. 2018 Mar;265(3):471-477. doi: 10.1007/s00415-017-8721-7. Epub 2017 Dec 28. J Neurol. 2018. PMID: 29285653 Free article.

7

Pharmacological Insights into the Use of Apomorphine in Parkinson's Disease: Clinical Relevance.

Auffret M, Drapier S, Vérin M. Auffret M, et al. Clin Drug Investig. 2018 Apr;38(4):287-312. doi: 10.1007/s40261-018-0619-3. Clin Drug Investig. 2018. PMID: 29327219 Review.

8

The Many Faces of Apomorphine: Lessons from the Past and Challenges for the Future.

Auffret M, Drapier S, Vérin M. Auffret M, et al. Drugs R D. 2018 Jun;18(2):91-107. doi: 10.1007/s40268-018-0230-3. Drugs R D. 2018. PMID: 29546602 Free PMC article. Review.

9

Correction to: The Many Faces of Apomorphine: Lessons from the Past and Challenges for the Future.

Auffret M, Drapier S, Vérin M. Auffret M, et al. Drugs R D. 2018 Jun;18(2):161. doi: 10.1007/s40268-018-0233-0. Drugs R D. 2018. PMID: 29737467 Free PMC article.

10

New tricks for an old dog: A repurposing approach of apomorphine.

Auffret M, Drapier S, Vérin M. Auffret M, et al. Eur J Pharmacol. 2019 Jan 15;843:66-79. doi: 10.1016/j.ejphar.2018.10.052. Epub 2018 Nov 2. Eur J Pharmacol. 2019. PMID: 30395851 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

179 results

Search Page

Filters